Search
Search
GenScript
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
图: 1 / 3
Reconstitute the lyophilized antibody with deionized water (or equivalent) to a final concentration of 0.5 mg/mL.
Pembrolizumab(Keytruda) is a humanized monoclonal antibody that is approved by the U.S. Foodand Drug Administration for the treatment of patients with unresectable ormetastatic melanoma. Pembrolizumab binds to the human cell surface receptorPD-1 (Programmed Cell Death Protein 1) and blocks its interaction with PD-L1,resulting in the activation of T-cell-mediated immune responses against tumorcells.GenScript MonoRab™ Anti-PembrolizumabAntibody (90G12F8) [Biotin], mAb, Rabbit is produced from ahybridoma resulting from the fusion of partner and B-lymphocytes obtained froma rabbit immunized with Pembrolizumab.
Upon reconstitution, it can be stored for 2-3 weeks at 2-8 °C or for up to 12 months at -20 °C or below.
Pembrolizumab (Keytruda) is a humanized monoclonal antibody that is approved by the U.S. Food and Drug Administration for the treatment of patients with unresectable or metastatic melanoma. Pembrolizumab binds to the human cell surface receptor PD-1 (Programmed Cell Death Protein 1) and blocks its interaction with PD-L1, resulting in the activation of T-cell-mediated immune responses against tumor cells.
仅用于科研。不用于诊断过程。未经明确授权不得转售。